HANSOH PHARMACEUTICAL GROUP COMPANY LIMITED

Other languages Hansoh Pharmaceutical Group Company Limited

Equities

3692

KYG549581067

Market Closed - Hong Kong S.E. Other stock markets 01:38:20 26/04/2024 pm IST			5-day change	1st Jan Change
17.22 ^HKD	+2.50%		+11.96%	+9.26%

03/04	Hansoh Pharmaceutical Secures Chinese Nod for Trial of Anti-Cancer Drug	MT
03/04	Hansoh Pharmaceutical Group Company Limited, Jiangsu Hansoh Pharmaceutical Group Company Limited and Shanghai Hansoh Biomedical Technology Company Limited Receives Grant of A Clinical Trial Notice Issued by the National Medical Products Administration of the People's Republic of China to Be Used for the Treatment of Advanced Non-Small Cell Lung Cancer	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Hansoh Pharmaceutical Secures Chinese Nod for Trial of Anti-Cancer Drug	03/04
Hansoh Pharmaceutical Group Company Limited, Jiangsu Hansoh Pharmaceutical Group Company Limited and Shanghai Hansoh Biomedical Technology Company Limited Receives Grant of A Clinical Trial Notice Issued by the National Medical Products Administration of the People's Republic of China to Be Used for the Treatment of Advanced Non-Small Cell Lung Cancer	03/04
Hansoh Pharmaceutical Group Company Limited Recommends Final Dividend, Payable on July 17, 2024	26/03
Hansoh Pharmaceutical Group Company Limited Reports Earnings Results for the Full Year Ended December 31, 2023	26/03
Hansoh Pharmaceutical Gets Nod to Trial Nephropathy Treatment Capsules	08/02
Hansoh Pharmaceutical Buys Back 3 Million Shares	31/01
Fed, China Property Outlooks Roil Asian Stock Markets	30/01
Hansoh Secures Chinese Nod For Clinical Trial Of Anti-Diabetes Drug	23/01
China Outlook, Tech Rally Roils Asian Stock Markets	19/01
Hansoh Pharmaceutical Group Company Limited Announces Clinical Trial Notice of HS-10509 Tablets	17/01
Federal Reserve Outlook Mutes Asian Stock Markets	05/01
GSK plc Enters Exclusive License Agreement with Hansoh for HS-20093	20/12
Games Workshop seals Amazon deal for Warhammer 40,000	18/12
GSK looks for deals in China as rebuilds relationship	17/12
Shanghai Hansoh Biomedical Technology Company Limited and Jiangsu Hansoh Pharmaceutical Group Company Limited Receives Clinical Trial Notice	10/11
Hansoh Pharmaceutical Group Company Limited Announces Clinical Trial Notice of Hs-20106 Injections	19/23/19
Las acciones de Hong Kong suben un 0,8%; las esperanzas de estímulo de China animan el ánimo -- Market Talk	27/23/27
Rising Interest Rates Blunt Asian Stock Markets	26/23/26
Hansoh Pharmaceutical Group Company Limited Announces Clinical Trial Notice of "HS-20105"	25/23/25
Hansoh Pharmaceutical Group’s Attributable Profit Slides in H1	01/23/01

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Hansoh Pharmaceutical Group Company Limited

Equities

3692

KYG549581067

Other languages

Filters